Teva Pharmaceutical Industries Cost of Goods Sold 2010-2024 | TEVA

Teva Pharmaceutical Industries cost of goods sold for the twelve months ending June 30, 2024 was $8.227B, a 0.33% increase year-over-year.

  • Teva Pharmaceutical Industries annual cost of goods sold for 2023 was $8.2B, a 3.12% increase from 2022.
  • Teva Pharmaceutical Industries annual cost of goods sold for 2022 was $7.952B, a 4.01% decline from 2021.
  • Teva Pharmaceutical Industries annual cost of goods sold for 2021 was $8.284B, a 7.27% decline from 2020.

Teva Pharmaceutical Industries Cost of Goods Sold 2010-2024 | TEVA

  • Teva Pharmaceutical Industries annual cost of goods sold for 2023 was $8.2B, a 3.12% increase from 2022.
  • Teva Pharmaceutical Industries annual cost of goods sold for 2022 was $7.952B, a 4.01% decline from 2021.
  • Teva Pharmaceutical Industries annual cost of goods sold for 2021 was $8.284B, a 7.27% decline from 2020.